In the previous period, more studies found that young age breast cancer presented advanced stages at diagnosis [14, 15], more aggressive pathological characteristics, a greater rate of triple-negative and HER2-overexpressing tumors [16], increased risk of locoregional recurrence in young women with breast cancer compared with older ones [17]. Here, ERBB2 is linked to breast cancer.